PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biostatistics, University of Washington, Seattle, WA, USA.\', \'Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases (NIAID/NIH), Bethesda, MD, USA.\', \'Office of Vaccines Research and Review, FDA/CBER, Silver Spring, MD, USA.\', \'Department of Biostatistics, University of Florida, Gainesville, FL, USA.\', \'World Health Organization, Geneva, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/17407745211018613
?:doi
?:hasPublicationType
?:journal
  • Clinical trials (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34041932
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 vaccine trials: The potential for \'hybrid\' analyses.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34041932>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34041932>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all